Results for tag: EGFR mutation Total Items Found: 8

Suresh Ramalingam on the FLAURA Trial

Type of Page:TapVideo
Edit This Item
Tags for this item:
egfr tki
EGFR mutation
esmo
lung cancer
nsclc
flaura trial
non-small cell lung cancer
osimertinib
tki
tyrosine kinase inhibitor

Created: 9/30/2019 2:08:20 PM

Naoki Furuya Results From the NEJ026 Study

Type of Page:TapVideo
Edit This Item
Tags for this item:
ASCO 2018
NSCLC
NEJ026 trial
bevacizumab
erlotinib
EGFR mutation
non-small cell lung cancer

Created: 6/4/2018 2:52:02 PM

Michèle Beau-Faller, MD, PhD, on NSCLC: Biomarker Findings From the French Cooperative Thoracic Intergroup

Type of Page:TapVideo
Edit This Item
Tags for this item:
ESMO 2017
Michele Beau-Faller
Hôpital de Hautepierre
Institut Régional du Cancer
NSCLC
lung cancer
ultrasensitive detection
EGFR T709M
droplet digital PCR
EGFR mutation

Created: 9/12/2017 10:38:29 AM

Luis G. Paz-Ares, MD, PhD, on NSCLC: Results from the LUX-Lung 7 Trial (Spanish Language Version)

Type of Page:TapVideo
Edit This Item
Tags for this item:
ESMO 2016
Luis Paz-Ares
Hospital Universitario 12 De Oct
lung cancer
NSCLC
non-small cell lung cancer
LUX-Lung 7 Trial
afatinib
geftinib
EGFR mutation

Created: 10/17/2016 1:55:05 PM

Luis G. Paz-Ares, MD, PhD, on NSCLC: Results from the LUX-Lung 7 Trial

Type of Page:TapVideo
Edit This Item
Tags for this item:
ESMO 2016
Luis Paz-Ares
Hospital Universitario 12 De Oct
lung cancer
NSCLC
non-small cell lung cancer
LUX-Lung 7 Trial
afatinib
geftinib
EGFR mutation

Created: 10/10/2016 7:48:41 AM

Tony Mok, MD, on NSCLC: Results of the IMPRESS Study

Type of Page:TapVideo
Edit This Item
Tags for this item:
ESMO 2016
Tony Mok
Chinese University of Hong Kong
lung cancer
non–small cell lung cancer
NSCLC
geftinib
chemotherapy
EGFR mutation

Created: 10/10/2016 5:34:34 AM

Rogerio Lilenbaum, MD, on Metastatic NSCLC: Managing EGFR-Mutation+ Disease

Type of Page:TapVideo
Edit This Item
Tags for this item:
2016 NCCN Annual Meeting
Rogerio Lilenbaum
Yale Cancer Center
Smilow Cancer Hospital
non–small cell lung cancer
NSCLC
EGFR mutation
tumor profiling
EGFR+ NSCLC

Created: 4/4/2016 11:19:29 AM

David E. Gerber, MD, and James L. Mulshine, MD, on Bringing Genomic Discovery and Targeted Therapies to Early-Stage Lung Cancer

Type of Page:TapVideo
Edit This Item
Tags for this item:
David Gerber
James Mulshine
UT Southwestern Medical Center
Rush University Medical Center
ASCO
NCI
ALCHEMIST
EGFR mutation
lung cancer
early-stage disease
molecular analyses
ALK positive
crizotinib
NCTN
erlotinib
community oncology
ASCO 2015

Created: 1/31/2016 9:04:21 AM
Order By Item Count
Order Alphabetically